Menu

Source of Scales, Feathers, Hair

Reptiles, birds, and mammals all produce tiny, bump-like structures during development.   

Jun 27, 2016
Tanya Lewis

From bottom to top: Wild type, heterozygous mutant, and homozygous mutant bearded dragons© MICHEL C. MILINKOVITCHReptile scales, bird feathers, and mammal hair all developed from the same structure in a common ancestor that lived some 300 million years ago, researchers have reported. Michel Milinkovitch of the University of Geneva, Switzerland, and colleagues found evidence of placodes—small bumps of thickened skin that develop in bird and mammal embryos—in bearded dragons, Nile crocodiles, and corn snakes, the team reported last week (June 24) in Science Advances. This was the first time these structures have been spotted in reptiles.

“People were fighting about the fact that reptiles either lost it, or birds and mammals independently developed them,” Milinkovitch told The New York Times. “Now we are lucky enough to put this debate to rest.”

Milinkovitch and colleagues were studying why some bearded dragons are born without scales, after finding such a naked specimen in a pet market. Genetic analysis revealed the involvement of a gene called EDA, which is known to interfere with the development of placodes in birds and mammals. When the researchers examined embryos from normal lizards, snakes, and crocodiles, they found the tiny bumps that had previously escaped their notice.

“This really closes some important questions,” Leopold Eckhart, a professor of dermatology at the Medical University of Vienna in Austria, who was not involved in the study, told Science.

The next step is to determine how the placodes in the common ancestor of reptiles, birds, and mammals led to the development of scales, feathers, and hair, respectively, evolutionary biologist Günter Wagner of Yale University told Science News.

November 2018

Intelligent Science

Wrapping our heads around human smarts

Marketplace

Sponsored Product Updates

LGC announces new, integrated, global portfolio brand, Biosearch Technologies, representing genomic tools for mission critical customer applications

LGC announces new, integrated, global portfolio brand, Biosearch Technologies, representing genomic tools for mission critical customer applications

LGC’s Genomics division announced it is transforming its branding under LGC, Biosearch Technologies, a unified portfolio brand integrating optimised genomic analysis technologies and tools to accelerate scientific outcomes.

DefiniGEN licenses CRISPR-Cas9 gene editing technology from Broad Institute to develop cell models for optimized metabolic disease drug development

DefiniGEN licenses CRISPR-Cas9 gene editing technology from Broad Institute to develop cell models for optimized metabolic disease drug development

DefiniGEN Ltd are pleased to announce the commercial licensing of CRISPR-Cas9 gene-editing technology from Broad Institute of MIT and Harvard in the USA, to develop human cell disease models to support preclinical metabolic disease therapeutic programmes.

Thermo Fisher Scientific: Freezers for Biological Samples

Thermo Fisher Scientific: Freezers for Biological Samples

Fluctuations in temperature can reduce the efficacy, decompose, or shorten the shelf life of biologics. Therefore, it is important to store biologics at the right temperature using standardized protocols.